Incyte filed required share ownership disclosure documents with the Securities and Exchange Commission on July 14, 2026.
4 reports, 2 independent
Updated Aug 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Incyte filed required share ownership disclosure documents with the Securities and Exchange Commission on July 14, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Incyte
American pharmaceutical company
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- ImmunityBio must disclose its holdings in compliance with SEC filing requirements.
- Iron Horse Acquisitions II Corp. filed disclosures with the Securities and Exchange Commission on September 14, 2026.
- Disclosure made to the Securities and Exchange Commission involving Northern Trust on July 2, 2026.
- Source Capital, Inc. filed required documents with the Securities and Exchange Commission regarding institutional ownership changes.
- Filings detail fund holdings for VGT with the Securities and Exchange Commission.